Latest news
This Week’s CGT News: In Vivo CAR T Draws Major Investment - The Medicine MakerThe Medicine Maker · Mon, 10 Aug 2026 13:21:07 GMTJ&J strikes CAR-T pact with Sail Bio, bags $2.58B buyout option - FirstWord PharmaFirstWord Pharma · Thu, 30 Jul 2026 12:26:36 GMTJ&J takes $2.58bn option to buy in vivo CAR-T firm Sail - pharmaphorumpharmaphorum · Thu, 30 Jul 2026 10:54:17 GMTJ&J pays Sail $785M, charting course to possible in vivo CAR-T buyout - Fierce BiotechFierce Biotech · Thu, 30 Jul 2026 07:00:00 GMTJ&J nabs option to buy ‘in vivo’ CAR-T maker Sail for nearly $2.6B - BioPharma DiveBioPharma Dive · Thu, 30 Jul 2026 07:00:00 GMTJ&J secures right to take the helm in up to $925M Sail CAR T pact - BioSpaceBioSpace · Thu, 30 Jul 2026 07:00:00 GMTSail Biomedicines Announces Strategic Collaboration to Develop New Class of Medicines for In Vivo CAR-T - Business WireBusiness Wire · Wed, 29 Jul 2026 07:00:00 GMT